Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Treasury Shares (2019 - 2025)

Historic Treasury Shares for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $257797.0.

  • Neurogene's Treasury Shares fell 4602.39% to $257797.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $257797.0, marking a year-over-year decrease of 4602.39%. This contributed to the annual value of $252124.0 for FY2024, which is N/A changed from last year.
  • Neurogene's Treasury Shares amounted to $257797.0 in Q3 2025, which was down 4602.39% from $271923.0 recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Treasury Shares peaked at $482384.0 during Q1 2024, and registered a low of $5750.0 during Q3 2023.
  • In the last 3 years, Neurogene's Treasury Shares had a median value of $264860.0 in 2025 and averaged $260009.8.
  • As far as peak fluctuations go, Neurogene's Treasury Shares skyrocketed by 820631.3% in 2024, and later tumbled by 4602.39% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Treasury Shares stood at $5750.0 in 2023, then soared by 4284.77% to $252124.0 in 2024, then grew by 2.25% to $257797.0 in 2025.
  • Its Treasury Shares was $257797.0 in Q3 2025, compared to $271923.0 in Q2 2025 and $279458.0 in Q1 2025.